Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement

BACKGROUND: Little is known about the treatment outcomes of secukinumab in clinical practice, which differ from those in clinical trials. The effectiveness of biologics may differ in psoriasis patients with previous biologics exposure. The objective of this study was to investigate the real-world ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Ger, Tzong-Yun, Huang, Yu-Huei, Hui, Rosaline Chung-yee, Tsai, Tsen-Fang, Chiu, Hsien-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472156/
https://www.ncbi.nlm.nih.gov/pubmed/31024679
http://dx.doi.org/10.1177/2040622319843756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472156/
https://www.ncbi.nlm.nih.gov/pubmed/31024679
http://dx.doi.org/10.1177/2040622319843756

Ejemplares similares